跳至主要内容
临床试验/NCT05626504
NCT05626504
进行中(未招募)
不适用

Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

King's College Hospital NHS Trust1 个研究点 分布在 1 个国家目标入组 50 人2022年10月27日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Brain Aneurysm
发起方
King's College Hospital NHS Trust
入组人数
50
试验地点
1
主要终点
Evaluate 30-day morbidity rates
状态
进行中(未招募)
最后更新
2年前

概览

简要总结

In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms

注册库
clinicaltrials.gov
开始日期
2022年10月27日
结束日期
2025年3月31日
最后更新
2年前
研究类型
Observational
性别
All

研究者

发起方
King's College Hospital NHS Trust
责任方
Sponsor

入排标准

入选标准

  • All patients treated with Pipeline Embolization Device with Vantage Technology (PEDV)
  • MRA and/or DSA (or tomographic angiography) available for follow up

排除标准

  • Insufficient background data available e.g., to determine size of aneurysm and pipeline device
  • PEDV used for causes other than aneurysms, e.g., fistulas and dissection.

结局指标

主要结局

Evaluate 30-day morbidity rates

时间窗: Done at 30 days post procedural

We will evaluate short term clinical outcome in the form of morbidity rates 30 days after the procedure

Evaluate 30-day mortality rates

时间窗: Done at 30 days post procedural

We will evaluate short term clinical outcome in the form of mortality rates 30 days after the procedure

次要结局

  • Evaluate 1-year morbidity rates(Done at >30days up to 1 year post procedural)
  • Evaluate 1-year mortality rates(Done at >30days up to 1 year post procedural)

研究点 (1)

Loading locations...

相似试验